HEATHER SCARBORO: Open Payments
NPI 1184243503 · NEWTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,253 in 73 payments from 19 companies in 2025. Trend: 2023 $4,602 · 2024 $5,352 · 2025 $4,253
Speaker / faculty: $2,875Food & beverage: $1,378
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $3,212 |
| Supernus Pharmaceuticals, Inc. | 10 | $190 |
| E.R. Squibb & Sons, L.L.C. | 4 | $107 |
| Axsome Therapeutics, Inc. | 4 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $80 |
| Corium, LLC | 3 | $73 |
| Collegium Pharmaceutical, Inc. | 4 | $72 |
| Vanda Pharmaceuticals Inc. | 2 | $60 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Lundbeck LLC | 2 | $53 |
Products named: VRAYLAR, Qelbree, COBENFY, REXULTI, Auvelity, CAPLYTA, Azstarys, Jornay PM.
Industry payments across PA — which companies pay providers there.
